Literature DB >> 23044993

Is the serum amyloid A we use really serum amyloid A? Comment on the article by Connolly et al.

Ben van den Brand, Claire Waterborg, Wim van den Berg, Fons van de Loo.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23044993     DOI： 10.1002/art.37737

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  8 in total

1.  High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation.

Authors:  Preetha Shridas; Maria C De Beer; Nancy R Webb
Journal:  J Biol Chem       Date:  2018-07-05       Impact factor: 5.157

2.  Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury.

Authors:  Ni Cheng; Yurong Liang; Xiaoping Du; Richard D Ye
Journal:  EMBO Rep       Date:  2018-08-20       Impact factor: 8.807

Review 3.  Serum amyloid A1: Structure, function and gene polymorphism.

Authors:  Lei Sun; Richard D Ye
Journal:  Gene       Date:  2016-03-03       Impact factor: 3.688

4.  Endogenous Acute Phase Serum Amyloid A Lacks Pro-Inflammatory Activity, Contrasting the Two Recombinant Variants That Activate Human Neutrophils through Different Receptors.

Authors:  Karin Christenson; Lena Björkman; Sofie Ahlin; Maja Olsson; Kajsa Sjöholm; Anna Karlsson; Johan Bylund
Journal:  Front Immunol       Date:  2013-04-22       Impact factor: 7.561

Review 5.  Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults.

Authors:  Mieke De Buck; Mieke Gouwy; Ji Ming Wang; Jacques Van Snick; Ghislain Opdenakker; Sofie Struyf; Jo Van Damme
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

6.  No evidence for a role of adipose tissue-derived serum amyloid a in the development of insulin resistance or obesity-related inflammation in hSAA1(+/-) transgenic mice.

Authors:  Sofie Ahlin; Maja Olsson; Bob Olsson; Per-Arne Svensson; Kajsa Sjöholm
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

7.  Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker.

Authors:  Yong Gil Hwang; Goundappa K Balasubramani; Ilinca D Metes; Marc C Levesque; S Louis Bridges; Larry W Moreland
Journal:  Arthritis Res Ther       Date:  2016-05-17       Impact factor: 5.156

8.  Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells.

Authors:  Tadeja Kuret; Katja Lakota; Polonca Mali; Saša Čučnik; Sonja Praprotnik; Matija Tomšič; Snezna Sodin-Semrl
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.